Zydus and Glenmark lead pharma growth in August 2026
Nomura said Zydus Lifesciences and Glenmark Pharma recorded the highest growth among its coverage universe in August 2026. It also reported semaglutide generics sales rose 2% month-on-month, while the India pharmaceuticals market grew 10.7% year-on-year.
Zydus Lifesciences and Glenmark Pharma posted the strongest growth in Nomura’s coverage universe in August 2026, the brokerage said in a September 8 note. Nomura said semaglutide generic sales increased 2% month on month. 7% year on year in August, driven by...